Acute rejection is associated with lower Hb levels, but it is not an independent predictor of post-renal transplant anemia, since it is generally associated with worse renal function, use of higher doses of myelotoxic immunosuppressants to control new episodes of rejection and use of drugs to inhibit RAAS. Here, GSTM1 is linked to anemia (phenotype).